Antacids Market

Antacids Market Outlook

Several aspects—ranging from unhealthy food habits, sedentary lifestyles, to regular intake of medicines to treat high blood pressure—increase acid levels in the stomach, which inadvertently increases the demand for antacids.

The recent past has witnessed wide availability of antacids in numerous formats, which are resonating well with consumers.

Manufacturers in the antacids market are approaching drug formulation techniques through consumer-centric means, in the form of chewable and flavored tablets, to score well in convenience regards. On the back of these factors, the exhaustive study by Fact.MR pegs the global antacids markets to soar to ~US$ 19 Billion by 2025.

Lenient legislations regarding the over-the-counter (OTC) availability of antacids are complementing the penetration of antacids through retail pharmacies, convenience stores, and hospital pharmacies.

In the future, market players will increase their budgets on research & development initiatives to differentiate their products by developing effective antacids.

Growing Popularity of Natural Therapeutics to Limit Sales Opportunities

Proton pump inhibitors (PPIs) are considered as standard antacids for the treatment of gastroesophageal reflux disease (also known as GERD). However, the prolonged use of these drugs—1 year or longer—is found to have an adverse impact on the kidneys and absorption level of vitamin B12.

Besides this, high doses of PPIs on a regular basis could increase the risk of spine, wrist, or hip fractures. As a result, rising awareness regarding the negative impact of PPIs is projected to reflect on the increasing production of H2 antagonist and acid neutralizers, which are emerging as strong alternatives for PPIs in the antacids market.

Despite the availability of effective substitutes for PPIs, consumers are looking at natural therapeutics to eliminate any grade of side-effect caused by antibiotics, which has been gaining ground to Ayurveda and Chinese treatments.

These treatments require cost-effective household ingredients to develop therapeutics, in order to cure acid reflux. Besides, the increasing inclination of consumers towards natural treatments could derail steady sales opportunities for players in the antacids market.

Why Increasing Investments in Gummy and Melt-in-Mouth Formulations is Deemed Lucrative

Convenience is a significant feature leading to an increase in the demand for antacids in the tablet format, which is expected to generate sales tantamount to ~US$ 13 Billion by 2025.

Tablets will remain the leading choice of consumers suffering from GERD, on the backdrop of their administered dosage, ease of consumption, and storage convenience. The availability of leading drug classes in the tablet format is further adding sheen to the growing popularity of tablets in the antacids market.

However, as manufacturers strive to reposition their brand identity, antacids in melt-in-mouth micro-granules and gummies are gaining traction. During the forecast period, these formulations are projected to record a marginal rise at a CAGR of ~5% in the antacids market.

Crucial Distribution Channels to Target across Key Regions

On a global level, players in the antacids market are targeting distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Among these, the over-the-counter availability of antacids is shifting lucrative sales opportunities from hospital pharmacies to others.

The unprecedented growth of e-Commerce channels coupled with the convenience of home delivery of therapeutics is turning online pharmacies as a standard distribution channel for antacids. However, the purchase behavior of consumers varies from region-to-region.

Europe is the leading antacids market, estimated to account for one-third of the total market share in 2025. Given the high penetration of smartphones and the popularity of the online-shopping culture, players operating in the antacids market in this region are recording a majority of sales through online pharmacies.

The prominence of online pharmacies is also likely to remain high in the North American antacids market, given the concentration of advanced pharmaceutical laboratories and availability of high-speed Internet connection, which encourages more sales through online channels.

In contrast to this, a significant chunk of revenue generated by the Asia Pacific antacids market is attributable to retail pharmacies; however, penetration of the smartphone culture and improvements in telecom services will create sales opportunities from online pharmacies, in the near future.

In a nutshell, players in the antacids market targeting developed regions can partner with online pharmacies, while those looking at developing regions can collaborate with retail pharmacies, and gradually move towards online channels.

Antacids Market – Segmentation Assessment

The global antacids market is segmented based on

• By Drug Class

  • Proton Pump Inhibitors
  • H2 Antagonists

• By Formulation

  • Tablets
  • Liquid
  • Powder
  • Others

• By Distribution Channel

  • Hospital Pharmacies
  • Retain Pharmacies

• By Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa

This study on the global antacids market has drug class, formulation, distribution channel, and region-specific data, along with market size valuation. It also has an in-depth forecast price point assessment of the same. The price index and the impact analysis of key regional and country-wise dynamics, also mentioned in the antacids market report, have been obtained through quotes from stakeholders and experts in the global antacids market. An in-depth analysis on the Y-o-Y growth projections of the antacids market is also included in this report.